Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke (Phase 4)

NCT00412867 is registered in ClinicalTrials.gov with Tanabe Pharma Corporation as lead sponsor.

NCT NCT00412867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00412867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke (Phase 4)
Lead sponsor
Tanabe Pharma Corporation
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2006
Completion date
June 30, 2008
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke